Back

Trends in home treatment and early discharge of patients with low-risk pulmonary embolism.

1 September 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: Treatment of acute pulmonary embolism across the strata risk Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Ioannis Farmakis

Ludwig Maximilians University, Munich (Germany)

8 More presentations in this session

Presentation thumbnail
Comparison of ultrasound-assisted thrombolysis and mechanical thrombectomy in patients with intermediate-high-risk pulmonary embolism
Doctor D. Pinsdorf (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Ultrasound assisted, catheter-directed thrombolysis for acute intermediate-high and high risk pulmonary embolism: focus on safety for oncological patients
Doctor C. Colombo (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Recent secular trends of catheter-directed therapy for treatment of pulmonary embolism: a retrospective cohort study based on German national data
Doctor V. Oettinger (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Right ventricular dysfunction parameters at echocardiography in patients with acute pulmonary embolism: meta-analysis of individual participant data
Doctor L. Cimini (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Mitigating health disparities by improving access to catheter-based therapies for vulnerable patients with acute pulmonary embolism
Doctor S. Bangalore (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of acute pulmonary embolism across the strata risk

The Event

Event poster

ESC Congress 2024

1 September 2024 18:00 CET
You may be interested in
thumbnail
Congress Session
Acute pulmonary embolism: new approaches for an old killer
thumbnail
Congress Presentation
Outcomes following catheter-directed therapy for intermediate-high risk acute pulmonary embolism
thumbnail
Congress Presentation
Strike PE

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources